AN1 0.00% 0.7¢ anagenics limited

Ann: Midkine Symposium Munich, page-64

  1. 412 Posts.
    lightbulb Created with Sketch. 26
    Latest news? Any clinical study to support it? In vivo and in vitro study always yield different result. I think cancer stem cell theory is faulty and depict an incomplete picture of latest understanding on cancer. I dont put high hope on targetting multiple cancer peptide targets will be the solution, cancer cells need surrounding good cells to flourish. 

    TBH, i heard the same thing 10, 20 years ago on 7 news, nine news abc news sbs news, and this current news, the way they did it, is nothing new in cancer therapy. 
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.000(0.00%)
Mkt cap ! $3.229M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $350 50K

Buyers (Bids)

No. Vol. Price($)
4 775527 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 5022 1
View Market Depth
Last trade - 11.14am 09/08/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.